This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

Professionals 225 Users Online

Non-opioid Analgesics Market

Non-opioid Analgesics Market - Global Industry Analysis 2014 - 2018 and Forecast 2019 - 2029

Non-opioid Analgesics Market Segmented By drug class such as NSAIDs, Acetaminophen, and Local Anaesthetics with pain type such as Post-operative Pain, Cancer Pain and Neuropathic Pain

Market Overview

Analgesics are the drugs used for the management of the pain. Pain is one of the most common phenomenon and around 85% of people are reported to suffer from pain worldwide at some point in their life. Pain can be of various types such as due to surgery, strain, etc.

Non-opioid analgesics are the drugs which are used for relieving pain, since use of most of the opioid drugs is abused at some stage by patient or any other person for non-medical use hence usage of opioid drugs is advised to lower by various healthcare professionals.

More than 56% of people across the world are reported to experience the body pain once a week whereas head pain affects around 23% once a week. More than 70,000 Americans died due to opioid abuse in 2017, which resulted in stringent regulatory measures by various regulatory bodies.

Increasing prevalence of the various chronic diseases such as cancer in which various treatments such as chemotherapy is responsible for the pain expected to drive the growth of the non-opioid analgesics market.

Increasing number of surgeries is expected to result in increased prevalence of post-operative pain which in turn expected to drive the growth of the non-opioid analgesics market. Increasing number of people suffering from neuropathic pain further expected to fuel the growth of non-opioid analgesics market.

Additional regulatory impositions on the opioid drugs is responsible for their limited market reach which in turn expected to drive the growth of the non-opioid analgesics market. Increasing support of various advocacy groups and KOLs to the non-opioid analgesics expected to drive the growth of the non-opioid analgesics market.

Lower cost of the non-opioid analgesics as compared to opioid drugs further expected to drive the growth of the non-opioid analgesics market. Worldwide reach of various regional and global non-opioid analgesics manufacturers resulted in the easy access to these drugs driving the growth of the non-opioid analgesics market. Whereas, frequent use of non-opioid analgesics is linked to various conditions such as decreased kidney functioning, increased risk of stroke, etc. may hamper the growth of the market.

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Market Segmentation

By drug class
  • NSAIDs
  • Acetaminophen
  • Local Anaesthetics
By pain type
  • Post-operative Pain
  • Cancer Pain
  • Neuropathic Pain
  • Others
By route of administration
  • Oral
  • Topical
  • Injectable
By distribution channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies
Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

Regional Outlook

The global non-opioid analgesics market is expected to be dominated by the North America due to higher prevalence of the pain. Europe is expected to be the second most lucrative region in the global non-opioid analgesics market owing to higher adoption of the analgesics.

Asia-Pacific is expected to be the fastest growing non-opioid analgesics market due to large population residing in countries such as India and China. Latin America market is expected to experience steady growth whereas MEA expected to be the least lucrative market due to lower adoption.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Key Players

The key participants operating in the global non-opioid analgesics market are: Iroko Pharmaceuticals, LLC, Pfizer Inc., Johnson & Johnson, MERCK, MIPHARM S.p.A., Novartis AG, Teva Pharmaceuticals, Mylan NV, and others

Prerna Shiv

Prerna Shiv
Client Partner

Let's Connect

Conect me to identify wining opportunities

Ask An Expert
I'm Available

The report covers exhaustive analysis on:

  • Non-opioid Analgesics Market Segments
  • Non-opioid Analgesics Market Dynamics
  • Historical Actual Market Size, 2013 - 2017
  • Non-opioid Analgesics Market Size & Forecast 2018 to 2024
  • Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Market Drivers and Restraints

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size recent industry trends
  • Key Competition landscape
  • Strategies for key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

- Companies Covered in This Report -

Google translate